Dow Inc. (DOW) Outperforms Broader Market: What You Need to Know

Dow Inc. (DOW) closed recently at $28.46, up 1.14% and outperforming the S&P 500, yet its stock has fallen 1.26% over the past month, trailing its sector and the broader market. Analysts project a significant decline for DOW's upcoming July 2025 earnings, forecasting -$0.08 EPS (down 111.76% year-over-year) and $10.35 billion in revenue (down 5.2%), with full-year estimates also sharply lower. The stock currently holds a Zacks Rank #4 (Sell) and trades at a premium valuation, including a Forward P/E of 105.65 and a PEG ratio of 11.1, both substantially above industry averages, signaling a challenging outlook within a low-ranked industry.

Analysis

Despite a recent single-day outperformance of 1.14% against the S&P 500, Dow Inc. (DOW) exhibits a fundamentally weak outlook. Over the past month, the stock has underperformed its sector and the broader market, falling 1.26%. Forward-looking indicators are particularly concerning, with analysts forecasting a loss of -$0.08 per share for the upcoming quarter, representing a 111.76% year-over-year decline. Full-year estimates are similarly bleak, projecting an 84.21% drop in earnings and a 3.02% decrease in revenue. This negative sentiment is reinforced by a significant 31.02% downward revision in the Zacks Consensus EPS estimate over the last month, culminating in a Zacks Rank of #4 (Sell). Furthermore, the stock's valuation appears stretched, with a Forward P/E ratio of 105.65 and a PEG ratio of 11.1, both representing substantial premiums to the industry averages of 15.07 and 2.1, respectively. These metrics suggest the current price is not supported by growth expectations, a risk compounded by the fact that DOW operates within the Chemical - Diversified industry, which ranks in the bottom 10% of all sectors.

Key Decisions for Investors

• Investors should view the recent daily stock gain with caution, as it contrasts sharply with deteriorating fundamentals, including a projected 111.76% year-over-year earnings decline in the next quarter.
• The stock's premium valuation, evidenced by a Forward P/E of 105.65 and a PEG of 11.1, presents a significant risk, as it appears disconnected from the negative consensus earnings and revenue forecasts.
• Given the persistent downward analyst revisions, the Zacks #4 (Sell) rating, and the weak industry backdrop, it may be prudent to avoid new long positions and for existing holders to re-evaluate their exposure ahead of the upcoming earnings report.